Stage I Ovarian Cancer: Jane's Survivor Story

Patient Info: Jane McGrath, female, 40s | Stage I

Jane was in remission after surgery and 6 rounds of chemotherapy and later became an ovarian-cancer volunteer and advocate.

Memorial Sloan KetteringRead more →

Stage IV Ovarian Cancer: Manisha's Survivor Story

Patient Info: Manisha Koirala, Female | Stage IV

She was declared cancer-free after her final chemotherapy cycle on April 30, 2013, and remained in remission more than 6 years later.

Memorial Sloan KetteringRead more →

Stage II Ovarian Squamous Cell Carcinoma: Caitlin's Survivor Story

Patient Info: Caitlin Koehler, female, Under 40 | Stage II

Biomarkers: PD-L1: high expression

After surgery for recurrence, Caitlin remained on maintenance therapy and her follow-up scans showed no evidence of disease.

MD AndersonRead more →

Stage IV Ovarian Cancer First Found Through an Umbilical Metastasis

Patient Info: Anonymized, female, 60s | Stage IV

Biomarkers: WT1-positive; CK7-positive; CA-125 321 U/mL at diagnosis

Metastatic Site: umbilicus

After 9 months of bevacizumab maintenance, her clinical and imaging findings remained stable.

PubMed CentralRead more →

Durable response after multiple treatments for ovarian clear cell cancer

Patient Info: Anonymized, Female, 40s | Stage III

Biomarkers: HRD-positive; BRCA-negative; ARID1A mutation; PD-L1 CPS 30

She achieved a complete response, completed maintenance immunotherapy in May 2024, and continued anlotinib with normal follow-up imaging and tumor markers.

PubMed CentralRead more →

Ovarian Cancer: Hope's Patient Story

Patient Info: Hope Aguilar, female

More than 14 years after her December 2011 diagnosis, Hope is a survivor and advocate after initial treatment and a later ovarian-cancer recurrence.

Ovarian Cancer Remission With Olaparib After Chemotherapy Intolerance

Patient Info: Anonymized, female, 50s | Stage III

Biomarkers: germline BRCA1 mutation

At 48 months, imaging showed complete remission and CA125 was normal while she continued reduced-dose olaparib.

PubMed CentralRead more →

Stage III BRCA1 Ovarian Cancer: Carla's Survivor Story

Patient Info: Carla Peoples, female | Stage III

Biomarkers: BRCA1 mutation

She was cancer-free after surgery and 6 rounds of chemotherapy and continued olaparib maintenance with CA-125 blood testing every 3 weeks.

MD AndersonRead more →

Ovarian Cancer: Lissa's Survivor Story

Patient Info: Lissa Fancher

At the latest update, the patient had no evidence of disease, tumor markers had dropped significantly, and daily hormone therapy was being used to reduce recurrence risk.

MD AndersonRead more →

Stage IV Ovarian Cancer: Susan's Patient Story

Patient Info: Susan Dunwoody, female | Stage IV

Susan lived for 7 years after her Stage IV ovarian cancer diagnosis and later died from the disease.

MD AndersonRead more →

Ovarian cancer chemotherapy continued after paclitaxel-related liver injury

Patient Info: Anonymized, Female, 50s | Stage II

Biomarkers: somatic BRCA1/2 negative

She completed all 6 planned chemotherapy cycles after dose reduction for liver toxicity and then entered routine surveillance.

PubMed CentralRead more →

Stage III Ovarian Cancer: Karoline's Patient Story

Patient Info: Karoline Strauss, female | Stage III

After resuming etigilimab and nivolumab, the patient felt markedly better; by the eighth infusion, some tumors had disappeared and others were shrinking, and treatment was continuing.

MD AndersonRead more →

Stage 4 Ovarian Cancer Discovered During Trigeminal Neuralgia Evaluation

Patient Info: Anonymized, Female, 50s | Stage IV

Three months after surgery, she had recovered well from debulking and 6 total chemotherapy cycles, with complete macroscopic clearance achieved at surgery. Trigeminal-neuralgia symptoms persisted and continued to require daily medication.

PubMed CentralRead more →

Emergency Surgery for a Malignant Brenner Tumor Causing Bowel Obstruction

Patient Info: Anonymized, Female, 60s

Biomarkers: CA-125 184.2 U/mL

A 62-year-old woman with a rare malignant Brenner tumor required emergency surgery after the ovarian mass caused bowel obstruction and a sealed perforation.

PubMed CentralRead more →

Ovarian cancer that later spread to an axillary lymph node

Patient Info: Anonymized, Female, 60s | Stage IV

Metastatic Site: axillary lymph nodes

After later peritoneal progression, additional treatment brought the disease to a stable state through her last recorded visit in July 2019.

PubMed CentralRead more →

Advanced Ovarian Cancer Presenting With Dermatomyositis

Patient Info: Anonymized, Female, 50s

Biomarkers: CA-125 3169 at diagnosis; later CA-125 rise with progression

After a partial response to second-line chemotherapy, nodal disease progressed again 5 months later and liposomal doxorubicin was planned.

PubMed CentralRead more →

Ovarian Cancer With Pleural Spread and Recurrent Dermatomyositis

Patient Info: Anonymized, Female, 40s | Stage Metastatic/Advanced

Metastatic Site: pleura

She had symptomatic improvement after 2 cycles of carboplatin and liposomal doxorubicin for recurrent disease.

PubMed CentralRead more →

Recurrent Ovarian Cancer With Dermatomyositis and Peritoneal Progression

Patient Info: Anonymized, Female, 50s

Her disease progressed during weekly paclitaxel, and she was considered unfit for further treatment.

PubMed CentralRead more →

Ovarian Cancer: Leslie's Survivor Story

Patient Info: Leslie Medley-Russell, female

Biomarkers: CA-125 elevated at recurrence

After treatment for the January 2017 recurrence, she had no evidence of disease at the time of the story.

MD AndersonRead more →

Ovarian Cancer With Severe Dermatomyositis During Treatment

Patient Info: Anonymized, female, 60s | Stage III

Biomarkers: BRCA1 mutation

She continued paclitaxel and carboplatin while being treated for severe dermatomyositis and later described herself as finally on the mend.

PubMed CentralRead more →

High-Grade Serous Ovarian Cancer With a Paraneoplastic Skin Condition

Patient Info: Anonymized, female, 60s

During first-line carboplatin and paclitaxel chemotherapy, the paraneoplastic skin changes regressed and the CA125 level returned to the normal range.

PubMed CentralRead more →

Ovarian Cancer Recurrence Complicated by a Benign Surgical Stitch Reaction

Patient Info: Anonymized, female, 40s | Stage III

Diffuse peritoneal relapse was confirmed, and she remained on third-line chemotherapy with persistent evidence of ovarian cancer.

PubMed CentralRead more →

Stage III BRCA1 Ovarian Cancer: Meredith's Survivor Story

Patient Info: Meredith Ippolito, female | Stage III

Biomarkers: BRCA1 mutation

Meredith was told she was cancer-free in April 2009 and continued follow-up visits every 6 months.

MD AndersonRead more →

Stage IV Ovarian Cancer: Bre's Patient Story

Patient Info: Bre Tipps, female, Under 40 | Stage IV

A recent CT scan showed the remaining tumors calcifying and dying during hormonal therapy, although the patient expected to need ongoing ovarian cancer treatment.

MD AndersonRead more →